Min Dai

960 total citations
26 papers, 771 citations indexed

About

Min Dai is a scholar working on Molecular Biology, Complementary and alternative medicine and Immunology. According to data from OpenAlex, Min Dai has authored 26 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Complementary and alternative medicine and 9 papers in Immunology. Recurrent topics in Min Dai's work include Traditional Chinese Medicine Analysis (10 papers), MicroRNA in disease regulation (7 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Min Dai is often cited by papers focused on Traditional Chinese Medicine Analysis (10 papers), MicroRNA in disease regulation (7 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Min Dai collaborates with scholars based in China. Min Dai's co-authors include Hongfei Wu, Junjun Chen, Yarong Liu, Lingyu Pan, Wenjun Hu, Chao Li, Yueqin Wang, Xiaoyan Shi, Hanwen Huang and Yin Sun and has published in prestigious journals such as Journal of Controlled Release, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Min Dai

25 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Dai China 16 419 176 167 146 124 26 771
Lizhu Lin China 19 633 1.5× 106 0.6× 126 0.8× 202 1.4× 92 0.7× 75 1.2k
Yanhao He China 19 387 0.9× 85 0.5× 69 0.4× 66 0.5× 131 1.1× 23 811
Yanni Lv China 17 387 0.9× 94 0.5× 112 0.7× 114 0.8× 73 0.6× 39 728
Qing Yuan China 11 338 0.8× 178 1.0× 44 0.3× 123 0.8× 117 0.9× 33 936
Simiao Qiao China 16 434 1.0× 172 1.0× 58 0.3× 102 0.7× 88 0.7× 32 865
Joen R. Sheu Taiwan 16 279 0.7× 103 0.6× 125 0.7× 87 0.6× 47 0.4× 24 874
Anne B. Hofseth United States 14 384 0.9× 105 0.6× 79 0.5× 138 0.9× 69 0.6× 16 777
Shuang Ren China 13 364 0.9× 82 0.5× 112 0.7× 87 0.6× 104 0.8× 32 757
Qiao Yang China 19 484 1.2× 63 0.4× 104 0.6× 131 0.9× 158 1.3× 48 1.1k
Baochang Lai China 15 400 1.0× 166 0.9× 34 0.2× 91 0.6× 114 0.9× 41 821

Countries citing papers authored by Min Dai

Since Specialization
Citations

This map shows the geographic impact of Min Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Dai more than expected).

Fields of papers citing papers by Min Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Dai. The network helps show where Min Dai may publish in the future.

Co-authorship network of co-authors of Min Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Min Dai. A scholar is included among the top collaborators of Min Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Dai. Min Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Gang, Jiajie Zhang, & Min Dai. (2025). Evaluating the resilience impacts of emission reduction policies in green liner shipping network along the New Maritime Silk Road. Regional Studies in Marine Science. 86. 104209–104209.
2.
Liu, Yarong, et al.. (2024). Extract of Gualou-Xiebai Herb Pair Improves Lipid Metabolism Disordersby Enhancing the Reverse Cholesterol Transport in Atherosclerosis Mice. Current Neurovascular Research. 21(2). 214–227. 2 indexed citations
4.
Wang, Wenjing, Zinan Zhao, Ziqiang Zhang, et al.. (2024). Delivery of small interfering RNA by hydrogen sulfide-releasing nanomotor for the treatment of Parkinson's disease. Journal of Controlled Release. 377. 648–660. 6 indexed citations
6.
Shi, Xiaoyan, Hongfei Wu, Yarong Liu, et al.. (2022). Inhibiting vascular smooth muscle cell proliferation mediated by osteopontin via regulating gut microbial lipopolysaccharide: A novel mechanism for paeonol in atherosclerosis treatment. Frontiers in Pharmacology. 13. 936677–936677. 23 indexed citations
7.
Shi, Xiaoyan, Hanwen Huang, Min Zhou, et al.. (2021). Paeonol Attenuated Vascular Fibrosis Through Regulating Treg/Th17 Balance in a Gut Microbiota-Dependent Manner. Frontiers in Pharmacology. 12. 765482–765482. 26 indexed citations
9.
Dong, Zhaomin, et al.. (2020). Paeonol prevents lipid metabolism dysfunction in palmitic acid-induced HepG2 injury through promoting SIRT1-FoxO1-ATG14-dependent autophagy. European Journal of Pharmacology. 880. 173145–173145. 20 indexed citations
10.
Shi, Xiaoyan, Ying Sun, Hai He, et al.. (2020). Paeonol inhibits NLRP3 mediated inflammation in rat endothelial cells by elevating hyperlipidemic rats plasma exosomal miRNA-223. European Journal of Pharmacology. 885. 173473–173473. 49 indexed citations
11.
Liu, Yarong, et al.. (2018). Paeonol Attenuated Inflammatory Response of Endothelial Cells via Stimulating Monocytes-Derived Exosomal MicroRNA-223. Frontiers in Pharmacology. 9. 1105–1105. 52 indexed citations
12.
Wang, Wei, Zhengzhu Zhang, Yan Wu, et al.. (2018). (–)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B. Frontiers in Pharmacology. 9. 195–195. 45 indexed citations
14.
Li, Chao, Li Yang, Hongfei Wu, & Min Dai. (2018). Paeonol Inhibits Oxidized Low-Density Lipoprotein-Induced Vascular Endothelial Cells Autophagy by Upregulating the Expression of miRNA-30a. Frontiers in Pharmacology. 9. 95–95. 37 indexed citations
15.
Chen, Junjun, et al.. (2016). Paeonol promotes microRNA-126 expression to inhibit monocyte adhesion to ox-LDL-injured vascular endothelial cells and block the activation of the PI3K/Akt/NF-κB pathway. International Journal of Molecular Medicine. 38(6). 1871–1878. 41 indexed citations
16.
Chen, Junjun, Min Dai, & Yueqin Wang. (2014). Paeonol Inhibits Proliferation of Vascular Smooth Muscle Cells Stimulated by High Glucose via Ras‐Raf‐ERK1/2 Signaling Pathway in Coculture Model. Evidence-based Complementary and Alternative Medicine. 2014(1). 484269–484269. 33 indexed citations
17.
Chen, Junjun, et al.. (2014). Paeonol protects rat vascular endothelial cells from ox-LDL-induced injury in vitro via downregulating microRNA-21 expression and TNF-α release. Acta Pharmacologica Sinica. 35(4). 483–488. 38 indexed citations
18.
Wang, Yueqin, et al.. (2012). Paeonol Inhibits Oxidized Low Density Lipoprotein-Induced Monocyte Adhesion to Vascular Endothelial Cells by Inhibiting the Mitogen Activated Protein Kinase Pathway. Biological and Pharmaceutical Bulletin. 35(5). 767–772. 29 indexed citations
20.
Dai, Min. (2007). Immunoloregulation effect of selenocarrageenan syrupus in mice. Zhongguo linchuang yaolixue yu zhiliaoxue. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026